These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32099636)

  • 1. The Immediate Pain-Relieving Effects of Non-Thermal CO
    Zand N; Mansouri P; Rezaee Khiabanloo S; Fateh M; Ataie-Fashtami L; Safaee Naraghi Z; Shirkavand A
    J Lasers Med Sci; 2020; 11(1):108-111. PubMed ID: 32099636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Effect of Non-Thermal CO2 Laser Therapy (NTCLT) on Pain Relief of Oral Aphthous Ulcers of Behçet's Disease.
    Zand N; Ataie-Fashtami L; Mansouri P; Fateh M; Shirkavand A
    J Lasers Med Sci; 2021; 12():e72. PubMed ID: 35155157
    [No Abstract]   [Full Text] [Related]  

  • 3. Relieving Pain in Oral Lesions of Pemphigus Vulgaris Using the Non-ablative, Non-thermal, CO
    Zand N; Mansouri P; Fateh M; Ataie-Fashtami L; Rezaee Khiabanloo S; Safar F; Chalangari R; Martits K; Shirkavand A
    J Lasers Med Sci; 2017; 8(1):7-12. PubMed ID: 28912937
    [No Abstract]   [Full Text] [Related]  

  • 4. Lenalidomide: An Alternative Treatment for Refractory Behçet's Disease and Relapsing Polychondritis.
    Brazão SG; Crespo J; Carvalho A
    Eur J Case Rep Intern Med; 2019; 6(6):001117. PubMed ID: 31293992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between periodontal parameters and Behçet's disease and evaluation of different treatments for oral recurrent aphthous stomatitis.
    Arabaci T; Kara C; Ciçek Y
    J Periodontal Res; 2009 Dec; 44(6):718-25. PubMed ID: 19076988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory Behçet's Disease with Multi-organ Involvement - Learning from Failure.
    Santos CS; Morales CM; Álvarez ED; Sandoval TP
    Curr Rheumatol Rev; 2021; 17(3):360-364. PubMed ID: 33371837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.
    Matsuda T; Ohno S; Hirohata S; Miyanaga Y; Ujihara H; Inaba G; Nakamura S; Tanaka S; Kogure M; Mizushima Y
    Drugs R D; 2003; 4(1):19-28. PubMed ID: 12568631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Level Laser Therapy to Reduce Recurrent Oral Ulcers in Behçet's Disease.
    Babu DB; Chavva S; Waghray S; Allam NS; Kondaiah M
    Case Rep Dent; 2016; 2016():4283986. PubMed ID: 27555969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoptysis Resolution with Rituximab in Behçet's Disease: A Case Report.
    Jamaati H; Eskandari R; Sharif-Kashani B; Haghgoo R; Dastan F
    Tanaffos; 2022 Mar; 21(3):401-404. PubMed ID: 37025315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genital ulcer severity score and genital health quality of life in Behçet's disease.
    Senusi A; Seoudi N; Bergmeier LA; Fortune F
    Orphanet J Rare Dis; 2015 Sep; 10():117. PubMed ID: 26394620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General manifestations of Behçet's syndrome and the success of CO2-laser as treatment for oral lesions: a review of the literature and case presentation.
    Demetriades N; Hanford H; Laskarides C
    J Mass Dent Soc; 2009; 58(3):24-7. PubMed ID: 19927952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease.
    Bacanli A; Yerebakan Dicle O; Parmaksizoglu B; Yilmaz E; Alpsoy E
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):931-5. PubMed ID: 16922940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of diode laser versus topical corticosteroid in management of Behcet's disease-associated oral ulcers: a randomized clinical trial.
    Nagieb CS; Harhash TA; Fayed HL; Ali S
    Clin Oral Investig; 2022 Jan; 26(1):697-704. PubMed ID: 34212234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behçet's disease physiopathology: a contemporary review.
    Zeidan MJ; Saadoun D; Garrido M; Klatzmann D; Six A; Cacoub P
    Auto Immun Highlights; 2016 Dec; 7(1):4. PubMed ID: 26868128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study.
    Nanke Y; Kamatani N; Okamoto T; Ogiuchi H; Kotake S
    Drugs R D; 2008; 9(6):455-9. PubMed ID: 18989994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Patients' Beliefs Regarding the Role of Food, Mucosal Trauma, Menstruation, and Psychological Stress in the Recurrence of Behçet's Disease Symptoms.
    Shenavandeh S; Asis M; Eftekhari MH; Aflaki E; Abdollahifard GR; Abnavi MA; Ahmadi A
    J Med Life; 2020; 13(2):164-169. PubMed ID: 32742508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Behcet's disease-associated oral ulcers on oral health related quality of life.
    Ali S; Nagieb CS; Fayed HL
    Spec Care Dentist; 2023; 43(4):435-442. PubMed ID: 36127751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathogenesis of Behcet's Disease.
    Tong B; Liu X; Xiao J; Su G
    Front Immunol; 2019; 10():665. PubMed ID: 30984205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of Behçet's disease with esophageal ulcers complicated with systemic sclerosis, chronic hepatitis C, and pancytopenia].
    Yokota K; Hirano M; Akiba H; Adachi D; Takeishi M; Akiyama Y; Mimura T
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Jun; 27(3):164-70. PubMed ID: 15291253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behçet's disease: minireview with emphasis on oral aspects.
    Giannetti L; Murri Dello Diago A; Lo Muzio L
    Minerva Stomatol; 2018 Dec; 67(6):246-249. PubMed ID: 29915169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.